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Extended daily dialysis versus intermittent hemodialysis for acute kidney injury: 
a systematic review 
 
To the Editor: 
 Acute kidney injury (AKI) occurs frequently during hospitalization[1] and is 
associated with deleterious effects[2,3]. The need for renal replacement therapy 
(RRT) in AKI is rising[4] and continuous RRT (CRRT), extended daily dialysis 
(EDD) and intermittent hemodialysis (IHD) are the most commonly used techniques 
in developed countries. Previous systematic reviews and meta-analysis have analyzed 
the use of RRT in AKI but failed to prove major outcome differences between CRRT 
and intermittent techniques, such as EDD and IHD[5-7]. Hemodynamic stability and 
the needed rate of solute clearance guide the clinical decision regarding dialytic 
modalities in AKI and evidence supporting the choice between IHD or EDD is 
limited[7]. Therefore, we aimed to systematically review published data comparing 
the safety and efficacy of EDD and IHD in AKI. 
 The protocol for this systematic review was pre-registered at PROSPERO 
(CRD42015025034) and the authors followed PRISMA guidelines (Annex S1). 
MEDLINE, CENTRAL (Cochrane Library), and clinicaltrials.gov were searched 
(June 2015) for studies comparing EDD and IHD in adult patients with AKI. Two 
independent authors selected studies, extracted data and evaluated the risk of bias. 
Primary outcomes were renal function recovery and mortality at 90 days. Secondary 
outcomes were intensive care unit (ICU) and hospital length of stay, hemodynamic 
stability, in-hospital mortality, and mortality at 30 days.  
 After deduplication 2735 studies were screened for eligibility, eight underwent 
full-text review and two were included[8,9] (Figure S1 - PRISMA flow diagram). 
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Study characteristics, baseline characteristics of patients and reported outcomes are 
summarized on Tables 1, 2, and 3, respectively. Both studies have an overall 
moderate risk of bias: Kumar et al[8] due to selection bias and Khanal et al[9] due to 
confounding bias, selection bias, reporting bias, and bias due to baseline imbalances. 
Kumar and colleagues[8] describe a quasi-randomized study including 30 
patients equally divided between arms. The mean age was 37.8 years (standard 
deviation (SD) 13.4), and most patients were women (n=23, 76.7%). The most 
frequent cause of AKI was sepsis (including 13 (43.3%) cases of obstetric sepsis), 
followed by hypovolemia. Extremely ill patients were excluded, less than half (n=13, 
43.3%) of patients exhibited dysfunction of two organs and only six (20%) required 
vasopressor use. At 90 days follow-up, all had recovered renal function and no deaths 
were reported. A non-significant trend towards a greater rate of intradialytic 
hypotension was observed for IHD. However, the blood flow rate in EDD was 
occasionally reduced to 200ml/min in response to vital sign changes. No data is 
provided for ICU or hospital length of stay, or intradialytic need to start or escalate 
vasopressors. 
 Khanal et al[9] describe a retrospective cohort study comparing the three most 
frequently used RRT in AKI, with 118 patients undergoing EDD and 20 IHD. The 
mean age was 57.7 years (SD 7.97), and most patients were men (n=81, 58.7%). 
Sepsis and surgery were the most frequent causes of AKI. Patients had high baseline 
illness severity, with elevated mean APACHE IV acute physiology score (108.62, SD 
37.96) and SOFA scores (12.40, SD 4.70) and rate of vasopressor use (n=118, 
85,5%). Of note, patients undergoing IHD had a lower baseline rate of vasopressor 
use when compared with EDD. Hazard ratios (IHD versus EDD) adjusted for baseline 
and time-varying characteristics were 1.22 (95%CI: 0.33-4.43) for in-hospital death 
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and 2.22 (95%CI: 0.49-10.11) for 90-day mortality. No data is provided for renal 
function recovery, mortality at 30 days, or for outcomes related to in-session 
hemodynamic stability. 
The two studies have disparate study designs and report on widely different 
populations, which compromises data aggregation and comparisons. The study by 
Kumar is interventional and its patients are characteristic of an underdeveloped 
country (young, with high rates of obstetric sepsis, hipovolemia, and malaria as 
causes of AKI), while Khanal reports on a severely ill population from a developed 
country. Also, Kumar’s small sample size and less ill patients may contribute to the 
excellent endpoints achieved (no deaths and all recovered renal function). Finally, 
Khanal and colleagues indicate that IHD patients were slightly less ill than the EDD 
ones but this effect may be limited by the baseline and time-varying modeled 
statistical analysis used. 
 This systematic review gathers very low-quality evidence (i.e., any estimate of 
effect is very uncertain[10]) suggesting that IHD may lead to greater intradialytic 
hemodynamic instability than EDD, and that both interventions may carry similar in-
hospital and 90-day risks of death. In the authors’ opinion, no strong 
recommendations can be made. Notwithstanding, one important result is the 
confirmation that the available data on this topic is very scarce: there are only two 
published studies, both with moderate risk of bias, suboptimal designs and sample 
sizes, and that missed to report all relevant outcomes. To drive patient care strong 
evidence is essential and this systematic review highlights the pressing need for 
studies comparing the safety and efficacy of EDD and IHD in AKI.
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Table 1 – Characteristics of included studies 
Source Study design Study 
centers 
Study 
period 
Setting Number 
of 
patients 
Inclusion 
criteria 
Definition of AKI Definition of 
interventions 
Reported 
causes of AKI 
Follow-
up 
Outcomes 
Kumar 
et al 
Quasi-
randomized 
interventional 
study 
1; India 2005-
2006 
Hospital 30 >14 <60 years 
old 
AKI 
Absence of 
CKD 
Absence of 
>2 failing 
organs 
Serum 
creatinine≥2.0mg/dL 
or an increase in 
serum creatinine>50% 
over the baseline value  
EDD: 8 hours 
per session, 
daily; 
IHD: 4 hours 
per session, 
thrice a week.  
 
 
 
Obstetric 
sepsis (43.3%) 
Hypovolemia 
(36.7% ) 
Malaria (10%) 
Other causes of 
sepsis (6.7%) 
Nephrotoxicity 
(3.3% ) 
90 days In-hospital 
mortality 
Recovery 
of renal 
function 
 
Khanal 
et al 
Retrospective 
cohort study 
1; New 
Zealand 
2002-
2008 
Intensive 
care unit 
138 >16 years old 
AKI or acute-
on-chronic 
renal disease 
except if 
CKD on 
maintenance 
dialysis 
RIFLE criteria EDD: 8 to 10 
hours per 
session, daily 
or on alternate 
days at 
physician 
discretion; 
IHD: 4 to 6 
hours per 
session, daily 
or on alternate 
days at 
physician 
discretion. 
Sepsis (69.6%) 
Postoperative 
(42%) 
90 days In-hospital 
mortality  
Mortality 
at 90 days 
AKI: acute kidney injury; CKD: chronic kidney disease; EDD: extended daily dialysis; IHD: intermittent hemodialysis; RIFLE: Renal Injury Failure Loss, End-stage kidney 
diseas
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Table 2 – Baseline characteristics of included patients 
 
Kumar et al. Khanal et al. 
IHD EDD IHD EDD 
Number of patients 15 15 20 118 
Age [mean (SD); years] 38.2  (12.2) 37.3 (15.0) 58.6 (17.6) 57.6 (4.9) 
Male [n (%)] 4  (26.7)  3 (25.0)  11 (55)  70 (59.3) 
Baseline eGFR [mean (SD); 
ml/min/1.73m
2
] 
N/A N/A 59.8 (40.0) 59.5 (29.4)  
Cause of AKI     
Sepsis [n (%)] 7  (46.7) 8 (53.3) 14 (70.0) 82 (69.5) 
Postoperative [n (%)] 0 (0.0) 0 (0.0) 6 (30.0) 52 (44.1) 
Nephrotoxicity [n 
(%)] 
1 (6.7)  0 (0.0) N/A N/A 
APACHE IV acute physiology 
score [mean (SD)] 
N/A N/A 100.7 (35.5) 108.9 (38.5)  
APACHE IV risk of death in 
% [mean (SD)] 
N/A N/A 68.3  (26.2)  67.7 (28.2) 
SOFA score [mean (SD)] N/A N/A 10.6 (4.4)  12.7 (4.7) 
Organ dysfunction     
1 organ [n (%)] 9 (60.0)  8 (53.3)  N/A N/A 
2 organs [n (%)] 6 (40.0)  7 (46.7)  N/A N/A 
Need of mechanical 
ventilatory support [n (%)] 
0 (0.0) 0 (0.0) N/A N/A 
Hemodynamic stability before 
dialysis 
    
MAP [mean (min-
max)] 
103.3 (89.9-
109.9) 
101.9 (99.9-
109) 
N/A N/A 
Need of vasopressor 
drugs [n (%)] 
3 (20.0) 3 (20.0) 15 (75.0) 103 (88.0) 
Number of dialytic sessions 82 140 55 413 
EDD: extended daily dialysis; IHD: intermittent hemodialysis; SD: standard deviation; N/A: not 
available; eGFR: estimated glomerular filtration rate; AKI: acute kidney injury; MAP: mean arterial 
pressure. 
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Table 3 – Reported outcomes of included studies 
 
Kumar et al Khanal et al 
IHD EDD 
Effect 
measure* 
IHD EDD 
Effect 
measure* 
Renal function recovery [n 
(%)] 
15 
(100) 
15 
(100) 
RR 1.00 
(0.88-1.13) 
N/A N/A N/A 
Mortality at 90 days [n (%)] 0 (0) 0 (0) 
RR 1.00 
(0.07-14.55) 
N/A N/A 
HR 2.22  
(0.49-10.11)  
Days in ICU [mean (SD)] N/A N/A N/A 
11.2 
(11.2) 
10.1 
(9.5) 
MD 1.1 (-
4.10-6.30) 
In-session hemodynamic 
stability 
      
Hypotensive 
episodes [n (%)] 
6 (7.3) 0 (0.0) 
RR 13.00 
(0.80-212.02) 
N/A N/A N/A 
Post-dialytic MAP 
[mean (min-max)] 
73 
(70-
79) 
78.6 
(75-83) 
Not estimable N/A N/A N/A 
In-hospital mortality [n (%)] 0 (0) 0 (0) 
RR 1.00 
(0.07-14.55) 
N/A N/A 
HR 1.22  
(0.33-4.43)  
Mortality at 30 days [n (%)] 0 (0) 0 (0) 
RR 1.00 
(0.07-14.55) 
N/A N/A N/A 
EDD: extended daily dialysis; IHD: intermittent hemodialysis; RR: risk ratio (95% confidence 
interval); N/A: Not available; HR: hazard ratio (95% confidence interval); ICU: intensive care unit; 
SD: standard deviation; MD: mean difference (SD); MAP: mean arterial pressure; *: IHD versus EDD  
